View source for AMHR2 (gene)

{{Infobox_gene}}

'''Anti-Mullerian hormone receptor type 2''' is a [[protein]] that in humans is encoded by the AMHR2 [[gene]].
<ref name="entrez">
{{cite web
| title = Entrez Gene: Anti-Mullerian hormone receptor type 2
| url = https://www.ncbi.nlm.nih.gov/gene/269
| accessdate = 2018-06-07
}}</ref>

==Function==

This gene encodes the receptor for the anti-Mullerian hormone (AMH) which, in addition to testosterone, results in male sex differentiation. AMH and testosterone are produced in the testes by different cells and have different effects. Testosterone promotes the development of male genitalia while the binding of AMH to the encoded receptor prevents the development of the mullerian ducts into uterus and Fallopian tubes. Mutations in this gene are associated with persistent Mullerian duct syndrome type II. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Sep 2009].

== References ==

{{reflist}}

== Further reading ==

{{refbegin | 2}}
*{{cite journal |vauthors=Teixeira J, Maheswaran S, Donahoe PK |title=Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications |journal=Endocr. Rev. |volume=22 |issue=5 |pages=657–74 |date=October 2001 |pmid=11588147 |doi=10.1210/edrv.22.5.0445 |url=}}
*{{cite journal |vauthors=Picard JY, Belville C |title=[Genetics and molecular pathology of anti-Mullerian hormone and its receptor] |language=French |journal=J. Soc. Biol. |volume=196 |issue=3 |pages=217–21 |date=2002 |pmid=12462075 |doi= |url=}}
*{{cite journal |vauthors=Wang HQ, Takakura K, Takebayashi K, Noda Y |title=Mutational analysis of the müllerian-inhibiting substance gene and its receptor gene in Japanese women with polycystic ovary syndrome and premature ovarian failure |journal=Fertil. Steril. |volume=78 |issue=6 |pages=1329–30 |date=December 2002 |pmid=12477536 |doi= |url=}}
*{{cite journal |vauthors=Salhi I, Cambon-Roques S, Lamarre I, Laune D, Molina F, Pugnière M, Pourquier D, Gutowski M, Picard JY, Xavier F, Pèlegrin A, Navarro-Teulon I |title=The anti-Müllerian hormone type II receptor: insights into the binding domains recognized by a monoclonal antibody and the natural ligand |journal=Biochem. J. |volume=379 |issue=Pt 3 |pages=785–93 |date=May 2004 |pmid=14750901 |pmc=1224123 |doi=10.1042/BJ20031961 |url=}}
*{{cite journal |vauthors=Kevenaar ME, Themmen AP, Laven JS, Sonntag B, Fong SL, Uitterlinden AG, de Jong FH, Pols HA, Simoni M, Visser JA |title=Anti-Müllerian hormone and anti-Müllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women |journal=Hum. Reprod. |volume=22 |issue=6 |pages=1547–54 |date=June 2007 |pmid=17337470 |doi=10.1093/humrep/dem036 |url=}}
*{{cite journal |vauthors=Kevenaar ME, Themmen AP, Laven JS, Sonntag B, Fong SL, Uitterlinden AG, de Jong FH, Pols HA, Simoni M, Visser JA |title=Anti-Müllerian hormone and anti-Müllerian hormone type II receptor polymorphisms are associated with follicular phase estradiol levels in normo-ovulatory women |journal=Hum. Reprod. |volume=22 |issue=6 |pages=1547–54 |date=June 2007 |pmid=17337470 |doi=10.1093/humrep/dem036 |url=}}
*{{cite journal |vauthors=Kevenaar ME, Themmen AP, Rivadeneira F, Uitterlinden AG, Laven JS, van Schoor NM, Lips P, Pols HA, Visser JA |title=A polymorphism in the AMH type II receptor gene is associated with age at menopause in interaction with parity |journal=Hum. Reprod. |volume=22 |issue=9 |pages=2382–8 |date=September 2007 |pmid=17636279 |doi=10.1093/humrep/dem176 |url=}}
*{{cite journal |vauthors=Kevenaar ME, Themmen AP, Rivadeneira F, Uitterlinden AG, Laven JS, van Schoor NM, Lips P, Pols HA, Visser JA |title=A polymorphism in the AMH type II receptor gene is associated with age at menopause in interaction with parity |journal=Hum. Reprod. |volume=22 |issue=9 |pages=2382–8 |date=September 2007 |pmid=17636279 |doi=10.1093/humrep/dem176 |url=}}
*{{cite journal |vauthors=Bakkum-Gamez JN, Aletti G, Lewis KA, Keeney GL, Thomas BM, Navarro-Teulon I, Cliby WA |title=Müllerian inhibiting substance type II receptor (MISIIR): a novel, tissue-specific target expressed by gynecologic cancers |journal=Gynecol. Oncol. |volume=108 |issue=1 |pages=141–8 |date=January 2008 |pmid=17988723 |doi=10.1016/j.ygyno.2007.09.010 |url=}}

{{refend}}


{{gene-12-stub}}
{{NLM content}}